Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NAPSA Antikörper (AA 189-299)

NAPSA Reaktivität: Human WB, IF, FACS, IHC (f) Wirt: Maus Monoclonal NAPSA-1238-NAPSA-1239 unconjugated
Produktnummer ABIN6938012
  • Target Alle NAPSA Antikörper anzeigen
    NAPSA (Napsin A Aspartic Peptidase (NAPSA))
    Bindungsspezifität
    • 13
    • 8
    • 8
    • 6
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 189-299
    Reaktivität
    • 72
    • 17
    • 10
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 49
    • 24
    Maus
    Klonalität
    • 42
    • 31
    Monoklonal
    Konjugat
    • 45
    • 6
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser NAPSA Antikörper ist unkonjugiert
    Applikation
    • 45
    • 28
    • 28
    • 15
    • 14
    • 10
    • 8
    • 7
    • 5
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Spezifität
    Napsin is a pepsin-like aspartic proteinase connected with maturation of surfactant protein B.There are two closely related napsins, napsin A and napsin B. Napsin A is expressed as a single chain protein. Immunohistochemical studies revealed high expression levels of napsin A in human lung and kidney but low expression in spleen. Napsin A is expressed in type II pneumocytes and in adenocarcinomas of lung. The high specificity expression of napsin A in adenocarcinomas of lung is useful to distinguish primary lung adenocarcinomas from adenocarcinomas of other organs.
    Kreuzreaktivität (Details)
    Human.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant human Napsin-A protein fragment (aa189-299) (exact sequence is proprietary)
    Klon
    NAPSA-1238-NAPSA-1239
    Isotyp
    IgG kappa
    Top Product
    Discover our top product NAPSA Primärantikörper
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL for 60 minutes at RT), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Lung adenocarcinoma.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    NAPSA (Napsin A Aspartic Peptidase (NAPSA))
    Andere Bezeichnung
    NAPSA (NAPSA Produkte)
    Hintergrund
    ASP4, Aspartyl protease 4, KAP, Kidney derived aspartic protease like protein (Kdap), NAP1, NAPA, Napsa, napsin A aspartic peptidase, Pronapsin A, SNAPA,Napsin A (Lung Adenocarcinoma Marker)
    Cellular localisation: Cytoplasmic
    Molekulargewicht
    37kDa
    Gen-ID
    9476, 512843
    UniProt
    O96009
    Pathways
    Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Sie sind hier:
Chat with us!